| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LianBio | Chief Financial Officer | Ordinary Shares | 326K | $539K | $1.65 | Mar 29, 2023 | Direct |
| Olema Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 23K | Jun 14, 2024 | Direct | ||
| RayzeBio, Inc. | Director | Employee Stock Option (right to buy) | 0 | Feb 26, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OLMA | Olema Pharmaceuticals, Inc. | Jun 14, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
| RYZB | RayzeBio, Inc. | Feb 26, 2024 | 3 | $0 | 4 | Feb 27, 2024 | Director |
| RYZB | RayzeBio, Inc. | Sep 14, 2023 | 0 | $0 | 3 | Sep 14, 2023 | Director |
| OLMA | Olema Pharmaceuticals, Inc. | Jun 16, 2023 | 1 | $0 | 4 | Jun 21, 2023 | Director |
| LIAN | LianBio | Mar 29, 2023 | 1 | $0 | 4 | Mar 31, 2023 | Chief Financial Officer |
| LIAN | LianBio | Jan 20, 2023 | 1 | $0 | 4 | Jan 24, 2023 | Chief Financial Officer |
| OLMA | Olema Pharmaceuticals, Inc. | Jun 17, 2022 | 1 | $0 | 4/A | Jun 27, 2022 | Director |
| OLMA | Olema Pharmaceuticals, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| LIAN | LianBio | Dec 1, 2021 | 1 | $0 | 4 | Dec 3, 2021 | Chief Financial Officer |
| LIAN | LianBio | Oct 31, 2021 | 1 | $0 | 4 | Nov 1, 2021 | Chief Financial Officer |
| LIAN | LianBio | Oct 29, 2021 | 0 | $0 | 3 | Oct 29, 2021 | Chief Financial Officer |
| OLMA | Olema Pharmaceuticals, Inc. | Jun 9, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |